Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study

CONCLUSION: Female patients with AF have different clinical profiles but similar efficacy and safety of AADs as compared to male participants. Propafenone has significantly lower efficacy in men, which requires further investigation.PMID:37997824 | DOI:10.33963/v.kp.97392

Source: Kardiologia Polska - November 24, 2023 Category: Cardiology Authors: Maciej T Wybraniec Aleksander Maci ąg Dawid Mi śkowiec Beata Ceynowa-Sielawko Pawe ł Balsam Maciej W ójcik Wojciech Wr óbel Micha ł Farkowski Edyta Ćwiek-Rębowska Marek Szo łkiewicz Krzysztof Oziera ński Robert B łaszczyk Karolina Bula Tomasz D Source Type: research